Cell Line : LN-229
Cellosaurus Index : CVCL_0393
Cellosaurus ID : LN-229
CTRP1 Name
, CTRP2 Name
: LN229
CCLE Name
: LN229_CENTRAL_NERVOUS_SYSTEM
GDSC1 Name
, GDSC2 Name
: LN-229
Cancer Type : central_nervous_system
Dataset : All
Drug Response Information
Click to show/hide information cards below or download all drug response information.
Information cards below will change according to the dataset selected. The default dataset is “All”, which means information in the cards is based on the integration. If “All” is not selected, information cards will contain drug response information preprocessed for each dataset independently.
Experimental information
Experimental information from All dataset, including cell line name, drug name, and minimum and maximum dosages used in each experiment. Click on Dose-response to query more detail for each experiment.
| Cellosaurus ID | Drug Name | Original Dataset(s) | Min Dose | Max Dose | Dose-response |
|---|---|---|---|---|---|
| LN-229 | (-)-gallocatechin-3-monogallate | CTRP1 | 2.3125 | 296.0000 |
|
| LN-229 | (5Z)-7-Oxozeaenol | GDSC1 | 0.0391 | 10.0000 |
|
| LN-229 | 10-DEBC | CTRP1 | 0.6250 | 80.0000 |
|
| LN-229 | 123138 | GDSC2 | 0.0010 | 1.0000 |
|
| LN-229 | 123829 | GDSC2 | 0.0030 | 3.0000 |
|
| LN-229 | 150412 | GDSC2 | 0.0030 | 3.0000 |
|
| LN-229 | 16-beta-bromoandrosterone | CTRP2,CTRP1 | 0.0011 | 37.0000 |
|
| LN-229 | 16,16-dimethylprostaglandin-E2 | CTRP1 | 0.2604 | 33.3330 |
|
| LN-229 | 1S,3R-RSL-3 | CTRP2,CTRP1 | 0.0010 | 33.0000 |
|
| LN-229 | 2-bromopyruvate | CTRP1 | 4.1667 | 533.3300 |
|
| LN-229 | 2-fluoropalmitic acid | CTRP1 | 1.1562 | 148.0000 |
|
| LN-229 | 2,4-dideoxy-DC-45-A2 | CTRP1 | 0.0163 | 2.0833 |
|
| LN-229 | 3-aminobenzamide | CTRP1 | 0.9564 | 122.4100 |
|
| LN-229 | 3-chloro-L-alanine | CTRP1 | 0.0163 | 2.0833 |
|
| LN-229 | 3-Cl-AHPC | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | 4-IPP | CTRP1 | 1.0417 | 133.3300 |
|
| LN-229 | 4-methylfasudil | CTRP1 | 1.0417 | 133.3300 |
|
| LN-229 | 5-azacytidine | GDSC2 | 0.0200 | 20.0000 |
|
| LN-229 | 5-Fluorouracil | GDSC1,GDSC2 | 0.0200 | 32.0000 |
|
| LN-229 | 50869 | GDSC2 | 0.0030 | 3.0000 |
|
| LN-229 | 6-diazo-5-oxo-L-norleucine | CTRP1 | 1.0417 | 133.3300 |
|
| LN-229 | 615590 | GDSC2 | 0.0030 | 3.0000 |
|
| LN-229 | 630600 | GDSC2 | 0.0030 | 3.0000 |
|
| LN-229 | 667880 | GDSC2 | 0.0030 | 3.0000 |
|
| LN-229 | 7-nitroindazole | CTRP1 | 2.0833 | 266.6700 |
|
| LN-229 | 720427 | GDSC2 | 0.0030 | 3.0000 |
|
| LN-229 | 729189 | GDSC2 | 0.0030 | 3.0000 |
|
| LN-229 | 741909 | GDSC2 | 0.0010 | 1.0000 |
|
| LN-229 | 743380 | GDSC2 | 0.0010 | 1.0000 |
|
| LN-229 | 765771 | GDSC2 | 0.0030 | 3.0000 |
|
| LN-229 | 776928 | GDSC2 | 0.0300 | 30.0000 |
|
| LN-229 | 965-D2 | GDSC1 | 0.0391 | 10.0000 |
|
| LN-229 | 968 | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | 993-D2 | GDSC1 | 0.0391 | 10.0000 |
|
| LN-229 | A-366 | GDSC2 | 0.0100 | 10.0000 |
|
| LN-229 | A-83-01 | GDSC1 | 0.0781 | 20.0000 |
|
| LN-229 | AA-COCF3 | CTRP2,CTRP1 | 0.0081 | 266.6700 |
|
| LN-229 | ABT-751 | CTRP1 | 0.2604 | 33.3330 |
|
| LN-229 | ABT737 | GDSC2,CTRP2,CTRP1 | 0.0011 | 37.0000 |
|
| LN-229 | AC55649 | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| LN-229 | Acetalax | GDSC2 | 0.0300 | 30.0000 |
|
| LN-229 | ACY-1215 | GDSC1 | 0.0781 | 20.0000 |
|
| LN-229 | AEW541 | CCLE | 0.0025 | 8.0000 |
|
| LN-229 | Afatinib | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | Afuresertib | GDSC2 | 0.0100 | 10.0000 |
|
| LN-229 | AG14361 | CTRP1 | 0.6510 | 83.3330 |
|
| LN-229 | AGI-5198 | GDSC2 | 0.0100 | 10.0000 |
|
| LN-229 | AGI-6780 | GDSC1,GDSC2 | 0.0020 | 10.0000 |
|
| LN-229 | AGK-2 | GDSC2,CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| LN-229 | AICA Ribonucleotide | GDSC1 | 7.8125 | 2000.0000 |
|
| LN-229 | AKT inhibitor VIII | GDSC1 | 0.0100 | 10.2400 |
|
| LN-229 | Alda-1 | CTRP1 | 1.0417 | 133.3300 |
|
| LN-229 | Alectinib | GDSC1 | 0.0200 | 5.1200 |
|
| LN-229 | Alisertib | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | alisertib:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| LN-229 | Alpelisib | GDSC2 | 0.0050 | 5.0000 |
|
| LN-229 | alpha-lipoic acid | GDSC2 | 0.1211 | 121.0000 |
|
| LN-229 | AM-580 | CTRP2,CTRP1 | 0.0160 | 533.3300 |
|
| LN-229 | AMG-319 | GDSC2 | 0.0100 | 10.0000 |
|
| LN-229 | Amuvatinib | GDSC1 | 0.0781 | 20.0000 |
|
| LN-229 | apicidin | CTRP2 | 0.0010 | 33.0000 |
|
| LN-229 | Apitolisib | GDSC1 | 0.0781 | 20.0000 |
|
| LN-229 | AR-42 | GDSC1 | 0.0200 | 5.1200 |
|
| LN-229 | Ara-G | GDSC1 | 0.0781 | 20.0000 |
|
| LN-229 | ARRY-520 | GDSC1 | 0.0010 | 0.2560 |
|
| LN-229 | AS601245 | GDSC1 | 0.0312 | 8.0000 |
|
| LN-229 | AS605240 | GDSC1 | 0.0781 | 20.0000 |
|
| LN-229 | ascorbate (vitamin C) | GDSC2 | 2.0011 | 2000.0000 |
|
| LN-229 | ASN 05257430 | CTRP2,CTRP1 | 0.0011 | 37.0000 |
|
| LN-229 | AST-1306 | GDSC1 | 0.0781 | 20.0000 |
|
| LN-229 | AT-7519 | GDSC1 | 0.0400 | 10.2400 |
|
| LN-229 | AT13148 | GDSC2 | 0.0100 | 10.0000 |
|
| LN-229 | AT7867 | GDSC1,CTRP2 | 0.0020 | 33.0000 |
|
| LN-229 | austocystin D | CTRP2,CTRP1 | 0.0011 | 37.0000 |
|
| LN-229 | Avagacestat | GDSC1,GDSC2 | 0.0100 | 10.2400 |
|
| LN-229 | avrainvillamide | CTRP1 | 0.2604 | 33.3330 |
|
| LN-229 | Axitinib | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | AZ-3146 | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | AZ20 | GDSC1 | 0.0391 | 10.0000 |
|
| LN-229 | AZ6102 | GDSC2 | 0.0100 | 10.0000 |
|
| LN-229 | AZ960 | GDSC2 | 0.0100 | 10.0000 |
|
| LN-229 | azacitidine | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | AZD-7545 | CTRP2,CTRP1 | 0.0023 | 74.0000 |
|
| LN-229 | AZD1208 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LN-229 | AZD1332 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LN-229 | AZD1480 | GDSC1 | 0.0098 | 2.5000 |
|
| LN-229 | AZD2014 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LN-229 | AZD3514 | GDSC1 | 0.0391 | 10.0000 |
|
| LN-229 | AZD3759 | GDSC2 | 0.0010 | 1.0000 |
|
| LN-229 | AZD4547 | GDSC1,GDSC2,CTRP2 | 0.0010 | 66.0000 |
|
| LN-229 | AZD4877 | GDSC1 | 0.0002 | 0.0390 |
|
| LN-229 | AZD5153 | GDSC2 | 0.0100 | 10.0000 |
|
| LN-229 | AZD5363 | GDSC2 | 0.0100 | 10.0000 |
|
| LN-229 | AZD5438 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LN-229 | AZD5582 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LN-229 | AZD5991 | GDSC2 | 0.0100 | 10.0000 |
|
| LN-229 | AZD6094 | GDSC1 | 0.0098 | 2.5000 |
|
| LN-229 | AZD6482 | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | AZD6738 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LN-229 | AZD7762 | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | AZD7969 | GDSC1 | 0.0391 | 10.0000 |
|
| LN-229 | AZD8055 | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | AZD8186 | GDSC1,GDSC2 | 0.0098 | 10.0000 |
|
| LN-229 | AZD8835 | GDSC1 | 0.0391 | 10.0000 |
|
| LN-229 | AZD8931 | GDSC1 | 0.0391 | 10.0000 |
|
| LN-229 | B02 | CTRP2,CTRP1 | 0.0041 | 133.3300 |
|
| LN-229 | BAM7 | GDSC1 | 0.0781 | 20.0000 |
|
| LN-229 | barasertib | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | bardoxolone methyl | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | batimastat | CTRP1 | 1.1562 | 148.0000 |
|
| LN-229 | Bax channel blocker | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| LN-229 | BAY ACCi | GDSC1 | 0.0391 | 10.0000 |
|
| LN-229 | BAY AKT1 | GDSC1 | 0.0391 | 10.0000 |
|
| LN-229 | BAY-61-3606 | GDSC1 | 0.0312 | 8.0000 |
|
| LN-229 | BAY-HDAC11_1 | GDSC1 | 0.0391 | 10.0000 |
|
| LN-229 | BAY-HDAC11_2 | GDSC1 | 0.0391 | 10.0000 |
|
| LN-229 | BAY-HDAC11_4 | GDSC1 | 0.0391 | 10.0000 |
|
| LN-229 | BAY-MPS-combo 2 (paclitaxel 1 uM) | GDSC1 | 0.0039 | 1.0000 |
|
| LN-229 | BAY-MPS-combo-1 (paclitaxel 5 uM) | GDSC1 | 0.0039 | 1.0000 |
|
| LN-229 | BAY-MPS1 | GDSC1 | 0.0117 | 3.0000 |
|
| LN-229 | BDF00022089a | GDSC2 | 0.0050 | 5.0000 |
|
| LN-229 | BDILV000379a | GDSC2 | 0.0050 | 5.0000 |
|
| LN-229 | BDOCA000347a | GDSC2 | 0.0020 | 2.0000 |
|
| LN-229 | BDP-00009066 | GDSC2 | 0.0100 | 10.0000 |
|
| LN-229 | BEC | CTRP2,CTRP1 | 0.0081 | 270.0000 |
|
| LN-229 | Belinostat | GDSC1 | 0.0781 | 20.0000 |
|
| LN-229 | BEN | GDSC2 | 0.0300 | 30.0000 |
|
| LN-229 | bendamustine | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | betulinic acid | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | Bexarotene | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | BI-2536 | GDSC2,CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| LN-229 | BIBF-1120 | GDSC1 | 0.0781 | 20.0000 |
|
| LN-229 | BIBR-1532 | GDSC2,CTRP2,CTRP1 | 0.0081 | 270.0000 |
|
| LN-229 | Bicalutamide | GDSC1 | 0.0040 | 10.0000 |
|
| LN-229 | birinapant | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | BIX-01294 | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| LN-229 | BIX02189 | GDSC1 | 0.0781 | 20.0000 |
|
| LN-229 | blebbistatin | CTRP2,CTRP1 | 0.0041 | 133.3300 |
|
| LN-229 | Bleomycin | GDSC1,GDSC2 | 0.0020 | 64.0000 |
|
| LN-229 | Bleomycin (10 uM) | GDSC1 | 0.0391 | 10.0000 |
|
| LN-229 | Bleomycin (50 uM) | GDSC1,GDSC2 | 0.0400 | 50.0000 |
|
| LN-229 | bleomycin A2 | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | BML-259 | CTRP1 | 2.0833 | 266.6700 |
|
| LN-229 | BMS-191011 | CTRP1 | 0.2604 | 33.3330 |
|
| LN-229 | BMS-195614 | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | BMS-270394 | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | BMS-299897 | CTRP1 | 0.2604 | 33.3330 |
|
| LN-229 | BMS-345541 | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | BMS-536924 | GDSC1,GDSC2,CTRP2,CTRP1 | 0.0011 | 37.0000 |
|
| LN-229 | BMS-641988 | CTRP1 | 0.2891 | 37.0000 |
|
| LN-229 | BMS-754807 | GDSC1,GDSC2,CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| LN-229 | Bortezomib | GDSC2,CTRP2,CTRP1 | 0.0000 | 0.1300 |
|
| LN-229 | Bosutinib | GDSC1,GDSC2 | 0.0020 | 2.0000 |
|
| LN-229 | BPD-00008900 | GDSC2 | 0.0100 | 10.0000 |
|
| LN-229 | BPTES | GDSC1 | 0.0391 | 10.0000 |
|
| LN-229 | BRD-A02303741 | CTRP2 | 0.0017 | 55.0000 |
|
| LN-229 | BRD-A02303741:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 4.2000 |
|
| LN-229 | BRD-A71883111 | CTRP2 | 0.0010 | 33.0000 |
|
| LN-229 | BRD-A94377914 | CTRP2 | 0.0010 | 33.0000 |
|
| LN-229 | BRD-K02251932 | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | BRD-K02492147 | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | BRD-K03536150 | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | BRD-K03911514 | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | BRD-K04800985 | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | BRD-K07442505 | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | BRD-K09587429 | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | BRD-K13185470 | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | BRD-K13999467 | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | BRD-K14844214 | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | BRD-K16130065 | CTRP2 | 0.0020 | 8.3000 |
|
| LN-229 | BRD-K16147474 | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | BRD-K17060750 | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | BRD-K19103580 | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | BRD-K20514654 | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | BRD-K24690302 | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | BRD-K27188169 | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | BRD-K27188169:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| LN-229 | BRD-K27224038 | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | BRD-K27986637 | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | BRD-K28456706 | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | BRD-K29086754 | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | BRD-K29313308 | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | BRD-K30019337 | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | BRD-K33199242 | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | BRD-K34099515 | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | BRD-K34222889 | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | BRD-K34485477 | CTRP2 | 0.0010 | 33.0000 |
|
| LN-229 | BRD-K35604418 | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | BRD-K37390332 | CTRP2 | 0.0010 | 33.0000 |
|
| LN-229 | BRD-K41334119 | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | BRD-K41597374 | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | BRD-K44224150 | CTRP2 | 0.0010 | 34.0000 |
|
| LN-229 | BRD-K45681478 | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | BRD-K48334597 | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | BRD-K49290616 | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | BRD-K50799972 | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | BRD-K51490254 | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | BRD-K52037352 | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | BRD-K55116708 | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | BRD-K58730230 | CTRP2 | 0.0020 | 33.0000 |
|
| LN-229 | BRD-K61166597 | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | BRD-K63431240 | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | BRD-K64610608 | CTRP2 | 0.0010 | 33.0000 |
|
| LN-229 | BRD-K66453893 | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | BRD-K66532283 | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | BRD-K70511574 | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | BRD-K71781559 | CTRP2 | 0.0041 | 66.0000 |
|
| LN-229 | BRD-K75293299 | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | BRD-K78574327 | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | BRD-K79669418 | CTRP2 | 0.0020 | 33.0000 |
|
| LN-229 | BRD-K80183349 | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | BRD-K84807411 | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | BRD-K85133207 | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | BRD-K86535717 | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | BRD-K88742110 | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | BRD-K92856060 | CTRP2 | 0.0010 | 0.5200 |
|
| LN-229 | BRD-K96431673 | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | BRD-K96970199 | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | BRD-K97651142 | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | BRD-K99584050 | CTRP2 | 0.0020 | 33.0000 |
|
| LN-229 | BRD0476 | CTRP1 | 0.2604 | 33.3330 |
|
| LN-229 | BRD0713 | CTRP1 | 0.6250 | 80.0000 |
|
| LN-229 | BRD1429 | CTRP1 | 0.2604 | 33.3330 |
|
| LN-229 | BRD1566 | CTRP1 | 0.2683 | 34.3400 |
|
| LN-229 | BRD1812 | CTRP2,CTRP1 | 0.0020 | 66.0000 |
|
| LN-229 | BRD1835 | CTRP2 | 0.0041 | 130.0000 |
|
| LN-229 | BRD2296 | CTRP1 | 0.2604 | 33.3330 |
|
| LN-229 | BRD2572 | CTRP1 | 0.6250 | 80.0000 |
|
| LN-229 | BRD2762 | CTRP1 | 0.6250 | 80.0000 |
|
| LN-229 | BRD32048 | CTRP1 | 0.2604 | 33.3330 |
|
| LN-229 | BRD4046 | CTRP1 | 0.6250 | 80.0000 |
|
| LN-229 | BRD4132 | CTRP2,CTRP1 | 0.0049 | 160.0000 |
|
| LN-229 | BRD4354 | CTRP1 | 0.2604 | 33.3330 |
|
| LN-229 | BRD4372 | CTRP1 | 0.6250 | 80.0000 |
|
| LN-229 | BRD4470 | CTRP1 | 0.2604 | 33.3330 |
|
| LN-229 | BRD4479 | CTRP1 | 0.1823 | 23.3330 |
|
| LN-229 | BRD4770 | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| LN-229 | BRD55319 | CTRP1 | 0.2891 | 37.0000 |
|
| LN-229 | BRD5586 | CTRP1 | 0.2604 | 33.3330 |
|
| LN-229 | BRD5802 | CTRP1 | 0.6250 | 80.0000 |
|
| LN-229 | BRD6150 | CTRP1 | 0.6250 | 80.0000 |
|
| LN-229 | BRD6340 | CTRP2,CTRP1 | 0.0010 | 40.0000 |
|
| LN-229 | BRD63610 | CTRP1 | 0.0081 | 1.0417 |
|
| LN-229 | BRD6368 | CTRP1 | 0.2604 | 33.3330 |
|
| LN-229 | BRD6413 | CTRP1 | 0.2604 | 33.3330 |
|
| LN-229 | BRD6430 | CTRP2,CTRP1 | 0.0020 | 33.3330 |
|
| LN-229 | BRD6825 | CTRP1 | 0.6250 | 80.0000 |
|
| LN-229 | BRD7137 | CTRP1 | 0.2604 | 33.3330 |
|
| LN-229 | BRD8097 | CTRP1 | 0.6250 | 80.0000 |
|
| LN-229 | BRD8418 | CTRP1 | 0.6250 | 80.0000 |
|
| LN-229 | BRD8899 | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| LN-229 | BRD8958 | CTRP2,CTRP1 | 0.0020 | 66.6670 |
|
| LN-229 | BRD9571 | CTRP1 | 0.6250 | 80.0000 |
|
| LN-229 | BRD9647 | CTRP2,CTRP1 | 0.0010 | 66.6670 |
|
| LN-229 | BRD9658 | CTRP1 | 0.6250 | 80.0000 |
|
| LN-229 | BRD9876 | CTRP2,CTRP1 | 0.0041 | 133.3300 |
|
| LN-229 | brefeldin A | CTRP2,CTRP1 | 0.0011 | 37.0000 |
|
| LN-229 | brivanib | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | Brivanib, BMS-540215 | GDSC1 | 0.0781 | 20.0000 |
|
| LN-229 | Bromosporine | GDSC2 | 0.0020 | 2.0000 |
|
| LN-229 | Bryostatin 1 | GDSC1 | 0.0000 | 0.0080 |
|
| LN-229 | Buparlisib | GDSC2 | 0.0100 | 10.0000 |
|
| LN-229 | BX-912 | GDSC1 | 0.0400 | 10.2400 |
|
| LN-229 | BX795 | GDSC1,CTRP1 | 0.0195 | 33.3330 |
|
| LN-229 | C-75 | GDSC1 | 0.0781 | 20.0000 |
|
| LN-229 | C6-ceramide | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | Cabozantinib | GDSC1,CTRP2 | 0.0200 | 66.0000 |
|
| LN-229 | Camptothecin | GDSC2 | 0.0001 | 0.1000 |
|
| LN-229 | canertinib | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | CAP-232, TT-232, TLN-232 | GDSC1 | 0.0781 | 20.0000 |
|
| LN-229 | Capivasertib | GDSC1 | 0.1172 | 30.0000 |
|
| LN-229 | capsaicin | CTRP1 | 4.1667 | 533.3300 |
|
| LN-229 | carbamazepine | CTRP1 | 2.5000 | 320.0000 |
|
| LN-229 | Carboplatin | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | carboplatin:etoposide (40:17 mol-mol) | CTRP2 | 0.0014 | 47.0000 |
|
| LN-229 | carboplatin:UNC0638 (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| LN-229 | Carmustine | GDSC2 | 0.0300 | 30.0000 |
|
| LN-229 | CAY10566 | GDSC1 | 0.0100 | 2.5600 |
|
| LN-229 | CAY10576 | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | CAY10594 | CTRP2,CTRP1 | 0.0020 | 66.6670 |
|
| LN-229 | CAY10603 | GDSC1 | 0.0781 | 20.0000 |
|
| LN-229 | CAY10618 | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| LN-229 | CCT-018159 | GDSC1 | 0.0391 | 10.0000 |
|
| LN-229 | CCT007093 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LN-229 | CCT036477 | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| LN-229 | CCT245232 | GDSC1 | 0.0008 | 0.2000 |
|
| LN-229 | CCT245467 | GDSC1 | 0.0008 | 0.2000 |
|
| LN-229 | CD-1530 | CTRP2,CTRP1 | 0.0041 | 133.3300 |
|
| LN-229 | CD-437 | CTRP2,CTRP1 | 0.0011 | 37.0000 |
|
| LN-229 | CD532 | GDSC1 | 0.0200 | 5.1200 |
|
| LN-229 | CDK9_5038 | GDSC2 | 0.0030 | 3.0000 |
|
| LN-229 | CDK9_5576 | GDSC2 | 0.0100 | 10.0000 |
|
| LN-229 | Cediranib | GDSC2 | 0.0100 | 10.0000 |
|
| LN-229 | ceranib-2 | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | cerulenin | CTRP2,CTRP1 | 0.0045 | 150.0000 |
|
| LN-229 | Cetuximab | GDSC1 | 0.2570 | 65.8000 |
|
| LN-229 | Ch-55 | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | chaetocin | CTRP1 | 0.0020 | 0.2600 |
|
| LN-229 | CHEMBL1222381 | CTRP2,CTRP1 | 0.0081 | 270.0000 |
|
| LN-229 | CHEMBL374350 | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| LN-229 | CHEMBL399379 | CTRP1 | 2.0833 | 266.6700 |
|
| LN-229 | CHIR-99021 | GDSC1,CTRP2,CTRP1 | 0.0024 | 80.0000 |
|
| LN-229 | chlorambucil | CTRP2 | 0.0081 | 270.0000 |
|
| LN-229 | CHM-1 | CTRP2,CTRP1 | 0.0005 | 16.0000 |
|
| LN-229 | CI-1033 | GDSC1 | 0.0781 | 20.0000 |
|
| LN-229 | CI-1040 | GDSC1 | 0.0391 | 10.0000 |
|
| LN-229 | CI-976 | CTRP2,CTRP1 | 0.0081 | 270.0000 |
|
| LN-229 | ciclopirox | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | ciclosporin | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| LN-229 | CID 2853753 | CTRP1 | 0.2604 | 33.3330 |
|
| LN-229 | CID-5951923 | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | CIL41 | CTRP2,CTRP1 | 0.0049 | 160.0000 |
|
| LN-229 | CIL55 | CTRP2,CTRP1 | 0.0003 | 10.0000 |
|
| LN-229 | CIL55A | CTRP2,CTRP1 | 0.0024 | 80.0000 |
|
| LN-229 | CIL56 | CTRP2,CTRP1 | 0.0001 | 2.5000 |
|
| LN-229 | CIL70 | CTRP2,CTRP1 | 0.0012 | 40.0000 |
|
| LN-229 | cimetidine | CTRP2 | 0.0081 | 270.0000 |
|
| LN-229 | Cisplatin | GDSC1,GDSC2 | 0.0040 | 10.0000 |
|
| LN-229 | clofarabine | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | Compound 10b | CTRP1 | 1.1562 | 148.0000 |
|
| LN-229 | Compound 110 | CTRP1 | 0.5781 | 74.0000 |
|
| LN-229 | Compound 11e | CTRP1 | 0.0130 | 1.6667 |
|
| LN-229 | Compound 12 | CTRP1 | 0.2891 | 37.0000 |
|
| LN-229 | Compound 1541A | CTRP2,CTRP1 | 0.0011 | 37.0000 |
|
| LN-229 | compound 1B | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | Compound 23 citrate | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| LN-229 | Compound 4 | CTRP1 | 0.2604 | 33.3330 |
|
| LN-229 | Compound 44 | CTRP1 | 1.0417 | 133.3300 |
|
| LN-229 | Compound 7d-cis | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| LN-229 | CP466722 | GDSC1 | 0.0625 | 16.0000 |
|
| LN-229 | CP724714 | GDSC1 | 0.0400 | 10.2400 |
|
| LN-229 | CPI-613 | GDSC1 | 1.0000 | 256.0000 |
|
| LN-229 | CPI-637 | GDSC2 | 0.0100 | 10.0000 |
|
| LN-229 | CR-1-31B | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| LN-229 | Crizotinib | GDSC2,CTRP2,CCLE | 0.0010 | 66.0000 |
|
| LN-229 | crizotinib:PLX-4032 (2:1 mol-mol) | CTRP2 | 0.0030 | 50.0000 |
|
| LN-229 | CRT0105446 | GDSC1 | 0.0391 | 10.0000 |
|
| LN-229 | CRT0105950 | GDSC1 | 0.0391 | 10.0000 |
|
| LN-229 | CRT0160829 | GDSC1 | 0.0781 | 20.0000 |
|
| LN-229 | CT7033-2 | GDSC2 | 0.0100 | 10.0000 |
|
| LN-229 | CUDC-101 | GDSC1 | 0.0200 | 5.1200 |
|
| LN-229 | curcumin | CTRP2,CTRP1 | 0.0051 | 170.0000 |
|
| LN-229 | CX-5461 | GDSC1 | 0.0400 | 10.2400 |
|
| LN-229 | cyanoquinoline 11 | CTRP2,CTRP1 | 0.0041 | 133.3300 |
|
| LN-229 | Cyclophosphamide | GDSC2,CTRP2 | 0.0041 | 130.0000 |
|
| LN-229 | CYT-997 | CTRP1 | 0.0260 | 3.3333 |
|
| LN-229 | Cytarabine | GDSC1,GDSC2 | 0.0020 | 2.0000 |
|
| LN-229 | cytarabine hydrochloride | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | cytochalasin B | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| LN-229 | cytosporone B | CTRP1 | 0.2604 | 33.3330 |
|
| LN-229 | CZC24832 | GDSC2 | 0.0100 | 10.0000 |
|
| LN-229 | Dabrafenib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LN-229 | Dacarbazine | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | Dacinostat | GDSC1 | 0.0040 | 1.0240 |
|
| LN-229 | Dactinomycin | GDSC2 | 0.0000 | 0.8000 |
|
| LN-229 | Dactolisib | GDSC1,GDSC2,CTRP1 | 0.0003 | 2.0833 |
|
| LN-229 | dalcetrapib | CTRP1 | 2.0687 | 264.8000 |
|
| LN-229 | Daporinad | GDSC1,CTRP2,CTRP1 | 0.0000 | 1.0000 |
|
| LN-229 | darinaparsin | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| LN-229 | Dasatinib | GDSC2,CTRP2 | 0.0010 | 66.0000 |
|
| LN-229 | DBeQ | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | DC-45-A2 | CTRP1 | 0.2891 | 37.0000 |
|
| LN-229 | Decitabine | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | decitabine:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | decitabine:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| LN-229 | dexamethasone | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| LN-229 | DG-041 | CTRP1 | 1.0417 | 133.3300 |
|
| LN-229 | Dihydrorotenone | GDSC2 | 0.0010 | 1.0000 |
|
| LN-229 | Dinaciclib | GDSC2 | 0.0010 | 1.0000 |
|
| LN-229 | DL-TBOA | CTRP1 | 4.1667 | 533.3300 |
|
| LN-229 | DMOG | GDSC1 | 15.6250 | 4000.0000 |
|
| LN-229 | Docetaxel | GDSC1,GDSC2 | 0.0000 | 3.0000 |
|
| LN-229 | docetaxel:tanespimycin (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| LN-229 | Doramapimod | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | Doxorubicin | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | doxorubicin:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| LN-229 | Dyrk1b_0191 | GDSC1 | 0.0391 | 10.0000 |
|
| LN-229 | eEF2K Inhibitor, A-484954 | GDSC1 | 0.0781 | 20.0000 |
|
| LN-229 | Eg5_9814 | GDSC2 | 0.0001 | 0.1000 |
|
| LN-229 | EHT-1864 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LN-229 | ELCPK | CTRP2,CTRP1 | 0.0000 | 0.4000 |
|
| LN-229 | Elephantin | GDSC2 | 0.0200 | 20.0000 |
|
| LN-229 | Elesclomol | GDSC1 | 0.0008 | 0.2000 |
|
| LN-229 | elocalcitol | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | Embelin | GDSC1 | 0.1250 | 32.0000 |
|
| LN-229 | endo-IWR-1 | CTRP1 | 0.2604 | 33.3330 |
|
| LN-229 | Entinostat | GDSC2,CTRP2 | 0.0100 | 33.0000 |
|
| LN-229 | Entospletinib | GDSC2 | 0.0100 | 10.0000 |
|
| LN-229 | Enzastaurin | GDSC1 | 0.0781 | 20.0000 |
|
| LN-229 | EphB4_9721 | GDSC1 | 0.0391 | 10.0000 |
|
| LN-229 | epigallocatechin-3-monogallate | CTRP2 | 0.0090 | 300.0000 |
|
| LN-229 | Epirubicin | GDSC2 | 0.0010 | 1.0000 |
|
| LN-229 | Epothilone B | GDSC1 | 0.0001 | 0.0320 |
|
| LN-229 | EPZ004777 | GDSC2 | 0.0100 | 10.0000 |
|
| LN-229 | EPZ5676 | GDSC2 | 0.0100 | 10.0000 |
|
| LN-229 | erastin | CTRP2,CTRP1 | 0.0020 | 66.0000 |
|
| LN-229 | erastin-A8 | CTRP1 | 0.1250 | 16.0000 |
|
| LN-229 | ERK_2440 | GDSC2 | 0.0100 | 10.0000 |
|
| LN-229 | ERK_6604 | GDSC2 | 0.0100 | 10.0000 |
|
| LN-229 | Erlotinib | GDSC2,CTRP2,CCLE | 0.0020 | 66.0000 |
|
| LN-229 | etomoxir | CTRP2,CTRP1 | 0.0090 | 300.0000 |
|
| LN-229 | Etoposide | GDSC1,CTRP2,CTRP1 | 0.0009 | 28.3180 |
|
| LN-229 | ETP-45835 | GDSC1 | 0.0781 | 20.0000 |
|
| LN-229 | fatostatin | CTRP1 | 0.2604 | 33.3330 |
|
| LN-229 | Fedratinib | GDSC1,CTRP2,CTRP1 | 0.0011 | 37.0000 |
|
| LN-229 | FEN1_3940 | GDSC1 | 0.0391 | 10.0000 |
|
| LN-229 | FGFR_0939 | GDSC1 | 0.0098 | 2.5000 |
|
| LN-229 | FGFR_3831 | GDSC1 | 0.0391 | 10.0000 |
|
| LN-229 | FGIN-1-27 | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| LN-229 | FH535 | GDSC1 | 0.1250 | 32.0000 |
|
| LN-229 | fingolimod | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | Flavopiridol | GDSC1 | 0.0100 | 2.5600 |
|
| LN-229 | Fludarabine | GDSC2 | 0.0200 | 20.0000 |
|
| LN-229 | fluoropyruvate | CTRP1 | 1.1562 | 148.0000 |
|
| LN-229 | fluorouracil | CTRP2 | 0.0041 | 130.0000 |
|
| LN-229 | Flutamide | CTRP1 | 0.7542 | 96.5330 |
|
| LN-229 | fluvastatin | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | FMK | GDSC1 | 0.0781 | 20.0000 |
|
| LN-229 | Foretinib | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | FQI-1 | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| LN-229 | FQI-2 | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| LN-229 | FR-180204 | GDSC1 | 0.0781 | 20.0000 |
|
| LN-229 | FS106 | GDSC1 | 0.0391 | 10.0000 |
|
| LN-229 | FS112 | GDSC1 | 0.0195 | 5.0000 |
|
| LN-229 | FSC231 | CTRP2 | 0.0081 | 270.0000 |
|
| LN-229 | FTI-277 | GDSC1 | 0.0040 | 1.0240 |
|
| LN-229 | FTY-720 | GDSC1 | 0.0781 | 20.0000 |
|
| LN-229 | Fulvestrant | GDSC1,GDSC2,CTRP2 | 0.0010 | 66.0000 |
|
| LN-229 | fumagillol | CTRP1 | 4.1667 | 533.3300 |
|
| LN-229 | fumonisin B1 | CTRP2,CTRP1 | 0.0150 | 504.0000 |
|
| LN-229 | FY012 | GDSC1 | 0.0391 | 10.0000 |
|
| LN-229 | FY026 | GDSC1 | 0.0391 | 10.0000 |
|
| LN-229 | FY069 | GDSC1 | 0.0391 | 10.0000 |
|
| LN-229 | Gallibiscoquinazole | GDSC2 | 0.0010 | 1.0000 |
|
| LN-229 | GANT-58 | CTRP1 | 0.2604 | 33.3330 |
|
| LN-229 | GANT-61 | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | GDC-0879 | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | GDC0810 | GDSC2 | 0.0100 | 10.0000 |
|
| LN-229 | Gefitinib | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | Gemcitabine | GDSC1,GDSC2,CTRP2,CTRP1 | 0.0001 | 10.0000 |
|
| LN-229 | Genentech Cpd 10 | GDSC1 | 0.0400 | 10.2400 |
|
| LN-229 | glibenclamide | CTRP1 | 0.2604 | 33.3330 |
|
| LN-229 | glutathione | GDSC2 | 0.6403 | 640.0000 |
|
| LN-229 | Gly-Gly-PALO | CTRP1 | 2.0833 | 266.6700 |
|
| LN-229 | GMX-1778 | CTRP2,CTRP1 | 0.0000 | 0.2900 |
|
| LN-229 | GNE-317 | GDSC2 | 0.0100 | 10.0000 |
|
| LN-229 | gossypol | CTRP2,CTRP1 | 0.0011 | 37.0000 |
|
| LN-229 | GSK-2334470 | CTRP1 | 0.0026 | 0.3333 |
|
| LN-229 | GSK-3 inhibitor IX | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | GSK-J4 | GDSC1 | 0.1172 | 30.0000 |
|
| LN-229 | GSK-LSD1 | GDSC2 | 0.0010 | 1.0000 |
|
| LN-229 | GSK-LSD1-2HCl | GDSC2 | 0.0010 | 1.0000 |
|
| LN-229 | GSK1059615 | GDSC1 | 0.0781 | 20.0000 |
|
| LN-229 | GSK1070916 | GDSC1 | 0.0100 | 2.5600 |
|
| LN-229 | GSK1904529A | GDSC1,GDSC2 | 0.0040 | 10.0000 |
|
| LN-229 | GSK2110183B | GDSC2 | 0.0030 | 3.0000 |
|
| LN-229 | GSK2256098C | GDSC2 | 0.0030 | 3.0000 |
|
| LN-229 | GSK2276186C | GDSC2 | 0.0100 | 10.0000 |
|
| LN-229 | GSK2578215A | GDSC2 | 0.0100 | 10.0000 |
|
| LN-229 | GSK2606414 | GDSC2 | 0.0100 | 10.0000 |
|
| LN-229 | GSK269962A | GDSC1 | 0.0195 | 5.0000 |
|
| LN-229 | GSK2801 | GDSC2 | 0.0100 | 10.0000 |
|
| LN-229 | GSK2830371 | GDSC2 | 0.0100 | 10.0000 |
|
| LN-229 | GSK2830371A | GDSC2 | 0.0030 | 10.0000 |
|
| LN-229 | GSK3337463A | GDSC2 | 0.0100 | 10.0000 |
|
| LN-229 | GSK343 | GDSC2 | 0.0010 | 10.0000 |
|
| LN-229 | GSK4112 | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | GSK429286A | GDSC1 | 0.0781 | 20.0000 |
|
| LN-229 | GSK461364 | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | GSK591 | GDSC2 | 0.0100 | 10.0000 |
|
| LN-229 | GSK626616AC | GDSC2 | 0.0001 | 0.1000 |
|
| LN-229 | GSK650394 | GDSC1 | 0.0625 | 16.0000 |
|
| LN-229 | GSK690693 | GDSC1 | 0.0400 | 10.2400 |
|
| LN-229 | GW-2580 | GDSC1 | 0.0781 | 20.0000 |
|
| LN-229 | GW-405833 | CTRP2,CTRP1 | 0.0041 | 133.3300 |
|
| LN-229 | GW441756 | GDSC1,GDSC2 | 0.0020 | 2.0000 |
|
| LN-229 | GW843682X | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| LN-229 | HG6-64-1 | GDSC1 | 0.0200 | 5.1200 |
|
| LN-229 | HKMTI-1-005 | GDSC2 | 0.0100 | 10.0000 |
|
| LN-229 | HLI 373 | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| LN-229 | hyperforin | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | I-BET-762 | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | I-BET151 | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | I-BRD9 | GDSC2 | 0.0100 | 10.0000 |
|
| LN-229 | I-CBP112 | GDSC1 | 0.0391 | 10.0000 |
|
| LN-229 | IAP_5620 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LN-229 | IAP_7638 | GDSC1 | 0.0391 | 10.0000 |
|
| LN-229 | Ibrutinib | GDSC2 | 0.0100 | 10.0000 |
|
| LN-229 | IC-87114 | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | ICL-SIRT078 | GDSC2 | 0.0100 | 10.0000 |
|
| LN-229 | ICL1100013 | GDSC1 | 0.0781 | 20.0000 |
|
| LN-229 | idarubicin | CTRP1 | 0.0020 | 0.2600 |
|
| LN-229 | Idelalisib | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | ifosfamide | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | IGF1R_3801 | GDSC2 | 0.0100 | 10.0000 |
|
| LN-229 | IGFR_3801 | GDSC1 | 0.0391 | 10.0000 |
|
| LN-229 | Imatinib | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | IMD-0354 | GDSC1 | 0.0781 | 20.0000 |
|
| LN-229 | importazole | CTRP2,CTRP1 | 0.0061 | 200.0000 |
|
| LN-229 | indisulam | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| LN-229 | IOX2 | GDSC1 | 0.0004 | 0.1000 |
|
| LN-229 | IPA-3 | GDSC1 | 0.1250 | 32.0000 |
|
| LN-229 | Ipatasertib | GDSC2 | 0.0100 | 10.0000 |
|
| LN-229 | IPR-456 | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | IRAK4_4710 | GDSC2 | 0.0100 | 10.0000 |
|
| LN-229 | Irinotecan | GDSC2 | 0.0050 | 10.0000 |
|
| LN-229 | isoevodiamine | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| LN-229 | isoliquiritigenin | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| LN-229 | ISOX | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| LN-229 | ISOX:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 |
|
| LN-229 | Ispinesib Mesylate | GDSC1 | 0.0005 | 0.1280 |
|
| LN-229 | itraconazole | CTRP2,CTRP1 | 0.0005 | 33.3330 |
|
| LN-229 | IU1 | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | IWP-2 | GDSC2 | 0.0010 | 1.0000 |
|
| LN-229 | JAK_8517 | GDSC2 | 0.0100 | 10.0000 |
|
| LN-229 | JAK1_3715 | GDSC1 | 0.0391 | 10.0000 |
|
| LN-229 | JAK1_8709 | GDSC2 | 0.0100 | 10.0000 |
|
| LN-229 | JAK3_7406 | GDSC1 | 0.0391 | 10.0000 |
|
| LN-229 | JNJ38877605 | GDSC1 | 0.0781 | 20.0000 |
|
| LN-229 | JNK Inhibitor VIII | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LN-229 | JNK-9L | GDSC1 | 0.0200 | 5.1200 |
|
| LN-229 | JQ-1:MK-0752 (1:1 mol-mol) | CTRP2 | 0.0081 | 66.0000 |
|
| LN-229 | JQ-1:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| LN-229 | JQ-1:vorinostat (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| LN-229 | JQ1 | GDSC1,GDSC2,CTRP2,CTRP1 | 0.0020 | 66.0000 |
|
| LN-229 | JQ12 | GDSC1 | 0.0200 | 5.1200 |
|
| LN-229 | JW-480 | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | JW-7-24-1 | GDSC1 | 0.0400 | 10.2400 |
|
| LN-229 | JZL-184 | CTRP1 | 0.2891 | 37.0000 |
|
| LN-229 | kahalalide F | CTRP1 | 0.2604 | 33.3330 |
|
| LN-229 | kb NB 142-70 | GDSC1 | 0.0781 | 20.0000 |
|
| LN-229 | KHS101 | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | Ki8751 | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | KIN001-042 | GDSC1 | 0.0400 | 10.2400 |
|
| LN-229 | KIN001-236 | GDSC1 | 0.0400 | 10.2400 |
|
| LN-229 | KIN001-244 | GDSC1 | 0.0781 | 20.0000 |
|
| LN-229 | KIN001-260 | GDSC1 | 0.0781 | 20.0000 |
|
| LN-229 | KIN001-266 | GDSC1 | 0.0781 | 20.0000 |
|
| LN-229 | KIN001-270 | GDSC1 | 0.0781 | 20.0000 |
|
| LN-229 | kinetin riboside | CTRP1 | 0.2604 | 33.3330 |
|
| LN-229 | Ko-143 | CTRP2,CTRP1 | 0.0041 | 133.3300 |
|
| LN-229 | Kobe2602 | GDSC1 | 0.0781 | 20.0000 |
|
| LN-229 | KRAS (G12C) Inhibitor-12 | GDSC2 | 0.0200 | 20.0000 |
|
| LN-229 | KU 0060648 | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| LN-229 | KU-0063794 | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | KU-55933 | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | KU-60019 | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | KW-2449 | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | KX2-391 | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | L-685458 | CTRP2,CCLE | 0.0011 | 37.0000 |
|
| LN-229 | L-Oxonoreleagnine | GDSC2 | 0.0030 | 3.0000 |
|
| LN-229 | Lapatinib | GDSC2,CTRP2,CCLE | 0.0020 | 66.0000 |
|
| LN-229 | LBH-589 | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | LBW242 | CCLE | 0.0025 | 8.0000 |
|
| LN-229 | LCL161 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LN-229 | LDN-193189 | GDSC1,CTRP1 | 0.0400 | 33.3330 |
|
| LN-229 | LE-135 | CTRP2,CTRP1 | 0.0020 | 66.6670 |
|
| LN-229 | Leflunomide | GDSC2 | 0.1001 | 100.0000 |
|
| LN-229 | Lenalidomide | GDSC1,GDSC2,CTRP1 | 0.0100 | 592.0000 |
|
| LN-229 | Lenvatinib | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | leptomycin B | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | Lestaurtinib | GDSC1,GDSC2 | 0.0020 | 2.0000 |
|
| LN-229 | leucascandrolide A | CTRP1 | 0.0163 | 2.0833 |
|
| LN-229 | LFM-A13 | GDSC1,CTRP1 | 0.0625 | 370.3700 |
|
| LN-229 | LGK974 | GDSC1,GDSC2 | 0.0050 | 10.0000 |
|
| LN-229 | LIMK1 inhibitor BMS4 | GDSC1 | 0.0781 | 20.0000 |
|
| LN-229 | Linifanib | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | Linsitinib | GDSC1,GDSC2,CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| LN-229 | LJI308 | GDSC2 | 0.0100 | 10.0000 |
|
| LN-229 | LMB_AB1 | GDSC2 | 0.0100 | 10.0000 |
|
| LN-229 | LMB_AB2 | GDSC2 | 0.0100 | 10.0000 |
|
| LN-229 | LMB_AB3 | GDSC2 | 0.0100 | 10.0000 |
|
| LN-229 | LMP744 | GDSC2 | 0.0030 | 3.0000 |
|
| LN-229 | lomeguatrib | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | lonidamine | CTRP1 | 4.6250 | 592.0000 |
|
| LN-229 | losartan | CTRP1 | 4.1667 | 533.3300 |
|
| LN-229 | lovastatin acid | CTRP2,CTRP1 | 0.0041 | 133.3300 |
|
| LN-229 | Luminespib | GDSC1,GDSC2 | 0.0003 | 1.0000 |
|
| LN-229 | LY-2157299 | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | LY-2183240 | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| LN-229 | LY2109761 | GDSC2 | 0.0100 | 10.0000 |
|
| LN-229 | m-3M3-FBS | CTRP1 | 2.0833 | 266.6700 |
|
| LN-229 | manumycin A | CTRP2,CTRP1 | 0.0009 | 30.2680 |
|
| LN-229 | maraviroc | CTRP1 | 0.2604 | 33.3330 |
|
| LN-229 | Masitinib | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | MCT1_6447 | GDSC1 | 0.0391 | 10.0000 |
|
| LN-229 | MCT4_1422 | GDSC1 | 0.0391 | 10.0000 |
|
| LN-229 | Mdivi-1 | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | MDV-3100 | CTRP1 | 0.0065 | 0.8333 |
|
| LN-229 | Merck60 | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| LN-229 | MetAP2 Inhibitor, A832234 | GDSC1 | 0.0100 | 2.5600 |
|
| LN-229 | Methotrexate | GDSC1,GDSC2,CTRP2 | 0.0008 | 66.0000 |
|
| LN-229 | MG-132 | GDSC2 | 0.0156 | 4.0000 |
|
| LN-229 | MGCD-265 | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | MI-1 | CTRP2 | 0.0010 | 33.0000 |
|
| LN-229 | Midostaurin | GDSC1 | 0.0020 | 0.5120 |
|
| LN-229 | MIM1 | GDSC1,GDSC2 | 0.0100 | 40.0000 |
|
| LN-229 | minoxidil | CTRP1 | 0.2604 | 33.3330 |
|
| LN-229 | MIRA-1 | GDSC2 | 0.0100 | 10.0000 |
|
| LN-229 | Mirin | GDSC1,GDSC2 | 0.1001 | 100.0000 |
|
| LN-229 | mitomycin | CTRP2 | 0.0015 | 50.0000 |
|
| LN-229 | Mitomycin-C | GDSC1 | 0.0625 | 16.0000 |
|
| LN-229 | Mitoxantrone | GDSC2 | 0.0030 | 3.0000 |
|
| LN-229 | MK-0752 | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | MK-1775 | GDSC2,CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| LN-229 | MK-2206 | GDSC1,GDSC2,CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| LN-229 | MK-591 | CTRP1 | 2.0833 | 266.6700 |
|
| LN-229 | MK-8776 | GDSC2 | 0.0050 | 5.0000 |
|
| LN-229 | ML006 | CTRP2,CTRP1 | 0.0160 | 533.3300 |
|
| LN-229 | ML007 | CTRP1 | 0.2891 | 37.0000 |
|
| LN-229 | ML013 | CTRP1 | 0.5208 | 66.6670 |
|
| LN-229 | ML030 | CTRP2,CTRP1 | 0.0020 | 66.0000 |
|
| LN-229 | ML050 | CTRP2,CTRP1 | 0.0020 | 66.6670 |
|
| LN-229 | ML100 | CTRP1 | 0.2604 | 33.3330 |
|
| LN-229 | ML101 | CTRP1 | 2.0833 | 266.6700 |
|
| LN-229 | ML150 | CTRP1 | 0.2604 | 33.3330 |
|
| LN-229 | ML159 | CTRP1 | 1.0417 | 133.3300 |
|
| LN-229 | ML160 | CTRP1 | 1.0417 | 133.3300 |
|
| LN-229 | ML162 | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| LN-229 | ML203 | CTRP2,CTRP1 | 0.0011 | 296.0000 |
|
| LN-229 | ML210 | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| LN-229 | ML214 | CTRP1 | 0.2604 | 33.3330 |
|
| LN-229 | ML239 | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | ML258 | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | ML311 | CTRP2 | 0.0010 | 66.0000 |
|
| LN-229 | ML312 | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | ML320 | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | ML323 | GDSC2 | 0.0200 | 20.0000 |
|
| LN-229 | MLN2238 | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| LN-229 | MN-64 | GDSC2 | 0.0100 | 10.0000 |
|
| LN-229 | momelotinib | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | Motesanib | GDSC1,GDSC2 | 0.0078 | 10.0000 |
|
| LN-229 | MPEP | CTRP1 | 0.2604 | 33.3330 |
|
| LN-229 | MPS-1-IN-1 | GDSC1 | 0.0781 | 20.0000 |
|
| LN-229 | Mycophenolic acid | GDSC2 | 0.0100 | 10.0000 |
|
| LN-229 | myricetin | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | myriocin | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| LN-229 | N-acetyl cysteine | GDSC2 | 2.0011 | 2000.0000 |
|
| LN-229 | N-oxalyl-D-phenylalanine | CTRP1 | 4.1667 | 533.3300 |
|
| LN-229 | N22899-6-C1 | GDSC1 | 0.0391 | 10.0000 |
|
| LN-229 | N23918-95-7 | GDSC1 | 0.0391 | 10.0000 |
|
| LN-229 | N24798-49-A1 | GDSC1 | 0.0391 | 10.0000 |
|
| LN-229 | N25720-51-A1 | GDSC2 | 0.0100 | 10.0000 |
|
| LN-229 | N27922-53-1 | GDSC2 | 0.0100 | 10.0000 |
|
| LN-229 | N29087-69-1 | GDSC2 | 0.0100 | 10.0000 |
|
| LN-229 | N30652-18-1 | GDSC2 | 0.0100 | 10.0000 |
|
| LN-229 | N9-isopropylolomoucine | CTRP2,CTRP1 | 0.0120 | 408.5000 |
|
| LN-229 | nakiterpiosin | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| LN-229 | narciclasine | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| LN-229 | Navitoclax | GDSC1,GDSC2,CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| LN-229 | navitoclax:birinapant (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| LN-229 | navitoclax:gemcitabine (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| LN-229 | navitoclax:MST-312 (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| LN-229 | navitoclax:pluripotin (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| LN-229 | navitoclax:PLX-4032 (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| LN-229 | navitoclax:sorafenib (1:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| LN-229 | necrostatin-1 | CTRP2,CTRP1 | 0.0160 | 533.3300 |
|
| LN-229 | necrostatin-7 | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | Nelarabine | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | neopeltolide | CTRP2,CTRP1 | 0.0000 | 33.0000 |
|
| LN-229 | neratinib | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| LN-229 | NG-25 | GDSC1 | 0.0400 | 10.2400 |
|
| LN-229 | niclosamide | CTRP2 | 0.0010 | 33.0000 |
|
| LN-229 | nifedipine | CTRP1 | 0.2604 | 33.3330 |
|
| LN-229 | Nilotinib | GDSC1,GDSC2,CTRP2,CCLE | 0.0020 | 66.0000 |
|
| LN-229 | nimodipine | CTRP1 | 0.2604 | 33.3330 |
|
| LN-229 | nintedanib | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | Niraparib | GDSC2 | 0.0100 | 10.0000 |
|
| LN-229 | NPC-26 | CTRP2,CTRP1 | 0.0012 | 40.0000 |
|
| LN-229 | NPK76-II-72-1 | GDSC1 | 0.0400 | 10.2400 |
|
| LN-229 | NSC 74859 | CTRP2,CTRP1 | 0.0160 | 533.3300 |
|
| LN-229 | NSC-207895 | GDSC1 | 0.0781 | 20.0000 |
|
| LN-229 | NSC-87877 | GDSC1 | 0.0625 | 16.0000 |
|
| LN-229 | NSC23766 | CTRP2,CTRP1 | 0.0160 | 533.3300 |
|
| LN-229 | NSC30930 | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | NSC319726 | GDSC1 | 0.0010 | 0.2560 |
|
| LN-229 | NSC48300 | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | NSC632839 | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| LN-229 | NSC95397 | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| LN-229 | NU 1025 | CTRP1 | 0.2604 | 33.3330 |
|
| LN-229 | NU7441 | GDSC1,GDSC2 | 0.0078 | 10.0000 |
|
| LN-229 | Nutlin-3a | CTRP1,CCLE,GDSC1,GDSC2,CTRP2 | 0.0025 | 150.0000 |
|
| LN-229 | NVP-231 | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | NVP-ADW742 | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | NVP-AUY922 | CTRP1 | 0.0001 | 33.3330 |
|
| LN-229 | NVP-BHG712 | GDSC1 | 0.0400 | 10.2400 |
|
| LN-229 | NVP-BSK805 | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | NVP-TAE684 | CTRP2,CCLE | 0.0020 | 66.0000 |
|
| LN-229 | Obatoclax Mesylate | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | OF-1 | GDSC2 | 0.0100 | 10.0000 |
|
| LN-229 | Olaparib | GDSC1,GDSC2,CTRP2,CTRP1 | 0.0045 | 150.0000 |
|
| LN-229 | oligomycin A | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| LN-229 | Omipalisib | GDSC1 | 0.0005 | 0.1280 |
|
| LN-229 | orteronel | CTRP1 | 1.0417 | 133.3300 |
|
| LN-229 | OSI-027 | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | OSI-930 | GDSC1,CTRP2 | 0.0020 | 33.0000 |
|
| LN-229 | Osimertinib | GDSC2 | 0.0010 | 1.0000 |
|
| LN-229 | OSU-03012 | GDSC1 | 0.0625 | 16.0000 |
|
| LN-229 | OSW-1 | CTRP1 | 0.0010 | 16.6670 |
|
| LN-229 | OTX015 | GDSC2 | 0.0100 | 10.0000 |
|
| LN-229 | ouabain | CTRP2 | 0.0081 | 270.0000 |
|
| LN-229 | Oxaliplatin | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | P-0850 | CTRP1 | 0.2604 | 33.3330 |
|
| LN-229 | P22077 | GDSC2 | 0.0100 | 10.0000 |
|
| LN-229 | PAC-1 | GDSC1,CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| LN-229 | Paclitaxel | GDSC2,CTRP2,CCLE | 0.0000 | 66.0000 |
|
| LN-229 | PAK_5339 | GDSC2 | 0.0300 | 30.0000 |
|
| LN-229 | Palbociclib | GDSC1,GDSC2,CCLE | 0.0025 | 10.0000 |
|
| LN-229 | pandacostat | CTRP2 | 0.0010 | 33.0000 |
|
| LN-229 | panduratin A | CTRP1 | 2.0833 | 266.6700 |
|
| LN-229 | Panobinostat | GDSC1,CCLE | 0.0025 | 8.0000 |
|
| LN-229 | parbendazole | CTRP2,CTRP1 | 0.0020 | 66.6670 |
|
| LN-229 | PARP_0108 | GDSC1 | 0.0098 | 2.5000 |
|
| LN-229 | PARP_9482 | GDSC1 | 0.0098 | 2.5000 |
|
| LN-229 | PARP_9495 | GDSC1 | 0.0098 | 2.5000 |
|
| LN-229 | Parthenolide | CTRP1 | 0.5208 | 66.6670 |
|
| LN-229 | Pazopanib | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | PBD-288 | GDSC2 | 0.0050 | 5.0000 |
|
| LN-229 | PCI-34051 | GDSC2 | 0.0100 | 10.0000 |
|
| LN-229 | PD0325901 | GDSC1,GDSC2,CCLE | 0.0003 | 8.0000 |
|
| LN-229 | PD173074 | GDSC1,GDSC2 | 0.0020 | 10.0000 |
|
| LN-229 | PD318088 | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | PDMP | CTRP2,CTRP1 | 0.0065 | 213.3300 |
|
| LN-229 | Pelitinib | GDSC1 | 0.0098 | 2.5000 |
|
| LN-229 | Pemetrexed | GDSC1,CTRP1 | 0.0100 | 296.0000 |
|
| LN-229 | penfluridol | CTRP1 | 0.7813 | 100.0000 |
|
| LN-229 | Pevonedistat | GDSC1,GDSC2,CTRP2,CTRP1 | 0.0011 | 37.0000 |
|
| LN-229 | PF-00299804 | GDSC1 | 0.0781 | 20.0000 |
|
| LN-229 | PF-04217903 | CTRP1 | 1.0417 | 133.3300 |
|
| LN-229 | PF-184 | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | PF-3845 | CTRP1 | 0.2604 | 33.3330 |
|
| LN-229 | PF-4708671 | GDSC1 | 0.0391 | 10.0000 |
|
| LN-229 | PF-562271 | GDSC1 | 0.0100 | 2.5600 |
|
| LN-229 | PF-573228 | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | PF-750 | CTRP2,CTRP1 | 0.0081 | 270.0000 |
|
| LN-229 | PFI-1 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LN-229 | PFI3 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LN-229 | PHA-665752 | CCLE | 0.0025 | 8.0000 |
|
| LN-229 | PHA-793887 | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | Phenformin | GDSC1 | 15.6250 | 4000.0000 |
|
| LN-229 | phloretin | CTRP2,CTRP1 | 0.0180 | 592.0000 |
|
| LN-229 | PI-103 | GDSC1,CTRP2,CTRP1 | 0.0011 | 37.0000 |
|
| LN-229 | PI3Ka_4409 | GDSC1 | 0.0391 | 10.0000 |
|
| LN-229 | Picolinici-acid | GDSC2 | 0.0100 | 10.0000 |
|
| LN-229 | Pictilisib | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | pifithrin-alpha | CTRP2,CTRP1 | 0.0071 | 232.7700 |
|
| LN-229 | pifithrin-mu | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| LN-229 | PIK-75 | CTRP1 | 0.0023 | 0.2890 |
|
| LN-229 | PIK-93 | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | Pilaralisib | GDSC1 | 0.0781 | 20.0000 |
|
| LN-229 | Piperlongumine | GDSC1,CTRP2,CTRP1 | 0.0010 | 35.6930 |
|
| LN-229 | PJ 34 | CTRP1 | 0.2604 | 33.3330 |
|
| LN-229 | PK-11195 | CTRP1 | 4.1667 | 533.3300 |
|
| LN-229 | PL-DI | CTRP2,CTRP1 | 0.0020 | 66.0000 |
|
| LN-229 | Platin | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | PLK_6522 | GDSC1 | 0.0024 | 0.6250 |
|
| LN-229 | pluripotin | CTRP2 | 0.0010 | 33.0000 |
|
| LN-229 | PLX-4032 | CTRP2 | 0.0010 | 33.0000 |
|
| LN-229 | PLX-4720 | GDSC1,GDSC2,CTRP2,CCLE | 0.0010 | 33.0000 |
|
| LN-229 | PNU-74654 | CTRP1 | 2.0833 | 266.6700 |
|
| LN-229 | Podophyllotoxin bromide | GDSC2 | 0.0010 | 1.0000 |
|
| LN-229 | POMHEX | GDSC2 | 0.0100 | 10.0000 |
|
| LN-229 | Ponatinib | GDSC1 | 0.0020 | 0.5120 |
|
| LN-229 | PP-30 | CTRP1 | 0.2891 | 37.0000 |
|
| LN-229 | PRIMA-1 | CTRP2,CTRP1 | 0.0051 | 170.0000 |
|
| LN-229 | PRIMA-1MET | GDSC2,CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| LN-229 | PRL-3 Inhibitor I | CTRP2,CTRP1 | 0.0041 | 133.3300 |
|
| LN-229 | procarbazine | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | prochlorperazine | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | PRT062607 | GDSC2 | 0.0100 | 10.0000 |
|
| LN-229 | PT-630 | CTRP1 | 0.2604 | 33.3330 |
|
| LN-229 | purmorphamine | CTRP2,CTRP1 | 0.0046 | 150.0000 |
|
| LN-229 | PX-12 | CTRP2,CTRP1 | 0.0030 | 100.0000 |
|
| LN-229 | PYR-41 | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | pyrazolanthrone | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | Pyridostatin | GDSC2 | 0.0100 | 10.0000 |
|
| LN-229 | pyrvinium pamoate | CTRP1 | 0.2604 | 33.3330 |
|
| LN-229 | QL-X-138 | GDSC1 | 0.0400 | 10.2400 |
|
| LN-229 | QL-XI-92 | GDSC1 | 0.0400 | 10.2400 |
|
| LN-229 | QL-XII-47 | GDSC1 | 0.0400 | 10.2400 |
|
| LN-229 | QS11 | GDSC1,CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| LN-229 | quinoclamine | CTRP1 | 0.2891 | 37.0000 |
|
| LN-229 | Quizartinib | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | RAF_9304 | GDSC1 | 0.0391 | 10.0000 |
|
| LN-229 | RAF265 | CTRP2,CCLE | 0.0020 | 66.0000 |
|
| LN-229 | Rapamycin | GDSC2,CTRP2,CTRP1 | 0.0000 | 37.0000 |
|
| LN-229 | Refametinib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LN-229 | Regorafenib | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | Remodelin | GDSC2 | 0.0500 | 50.0000 |
|
| LN-229 | Repligen 136 | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | RG-108 | CTRP2,CTRP1 | 0.0081 | 270.0000 |
|
| LN-229 | Ribociclib | GDSC2 | 0.0020 | 2.0000 |
|
| LN-229 | rigosertib | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | RITA | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| LN-229 | Ro-28-1675 | CTRP1 | 4.1667 | 533.3300 |
|
| LN-229 | RO-3306 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LN-229 | Romidepsin | GDSC2 | 0.0000 | 0.0100 |
|
| LN-229 | rosiglitazone | CTRP1 | 2.0833 | 266.6700 |
|
| LN-229 | rotenone | CTRP1 | 0.0163 | 2.0833 |
|
| LN-229 | RS-23597-190 | CTRP1 | 4.1667 | 533.3300 |
|
| LN-229 | rTRAIL | GDSC1 | 0.0004 | 0.1000 |
|
| LN-229 | RU-SKI 43 | GDSC1 | 0.0781 | 20.0000 |
|
| LN-229 | Rucaparib | GDSC1,GDSC2,CTRP1 | 0.0050 | 33.3330 |
|
| LN-229 | Ruxolitinib | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | RVX-208 | GDSC2 | 0.0100 | 10.0000 |
|
| LN-229 | Sabutoclax | GDSC2 | 0.0100 | 10.0000 |
|
| LN-229 | salermide | CTRP1 | 3.1250 | 400.0000 |
|
| LN-229 | salermide:PLX-4032 (12:1 mol-mol) | CTRP2 | 0.0130 | 220.0000 |
|
| LN-229 | Sapitinib | GDSC2 | 0.0050 | 10.0000 |
|
| LN-229 | Saracatinib | CTRP2,CCLE | 0.0020 | 66.0000 |
|
| LN-229 | Savolitinib | GDSC2 | 0.0010 | 1.0000 |
|
| LN-229 | SB-225002 | CTRP2,CTRP1 | 0.0011 | 37.0000 |
|
| LN-229 | SB-431542 | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | SB-525334 | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | SB-743921 | CTRP2 | 0.0010 | 33.0000 |
|
| LN-229 | SB216763 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LN-229 | SB505124 | GDSC1 | 0.0391 | 20.0000 |
|
| LN-229 | SB52334 | GDSC1 | 0.0781 | 20.0000 |
|
| LN-229 | SB590885 | GDSC1,GDSC2 | 0.0050 | 5.0000 |
|
| LN-229 | SCH-529074 | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| LN-229 | SCH-79797 | CTRP2,CTRP1 | 0.0011 | 37.0000 |
|
| LN-229 | SCH772984 | GDSC2 | 0.0050 | 5.0000 |
|
| LN-229 | Schweinfurthin A | GDSC2 | 0.0010 | 1.0000 |
|
| LN-229 | Selisistat | GDSC1,CTRP2,CTRP1 | 0.0024 | 80.0000 |
|
| LN-229 | Selumetinib | CTRP1,CCLE,GDSC1,GDSC2,CTRP2 | 0.0025 | 270.0000 |
|
| LN-229 | selumetinib:BRD-A02303741 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| LN-229 | selumetinib:decitabine (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| LN-229 | selumetinib:GDC-0941 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| LN-229 | selumetinib:JQ-1 (4:1 mol-mol) | CTRP2 | 0.0051 | 42.0000 |
|
| LN-229 | selumetinib:MK-2206 (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| LN-229 | selumetinib:navitoclax (8:1 mol-mol) | CTRP2 | 0.0730 | 150.0000 |
|
| LN-229 | selumetinib:piperlongumine (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| LN-229 | selumetinib:PLX-4032 (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| LN-229 | selumetinib:tretinoin (2:1 mol-mol) | CTRP2 | 0.0061 | 200.0000 |
|
| LN-229 | selumetinib:UNC0638 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| LN-229 | selumetinib:vorinostat (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| LN-229 | semagacestat | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | Sepantronium bromide | GDSC1,GDSC2,CTRP2,CTRP1 | 0.0001 | 10.0000 |
|
| LN-229 | Serdemetan | GDSC1,GDSC2,CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| LN-229 | serdemetan:SCH-529074 (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| LN-229 | SGC-CBP30 | GDSC2 | 0.0050 | 5.0000 |
|
| LN-229 | SGC0946 | GDSC1,GDSC2 | 0.0005 | 0.5000 |
|
| LN-229 | SGX-523 | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | Shikonin | GDSC1 | 0.0625 | 16.0000 |
|
| LN-229 | SID 26681509 | CTRP2,CTRP1 | 0.0090 | 300.0000 |
|
| LN-229 | sildenafil | CTRP2,CTRP1 | 0.0160 | 533.3300 |
|
| LN-229 | silmitasertib | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | simvastatin | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| LN-229 | Sinularin | GDSC2 | 0.0030 | 3.0000 |
|
| LN-229 | sirolimus:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 |
|
| LN-229 | sitagliptin | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | SJ-172550 | CTRP2,CTRP1 | 0.0010 | 37.0000 |
|
| LN-229 | SKI-II | CTRP2,CTRP1 | 0.0041 | 133.3300 |
|
| LN-229 | SL0101 | GDSC1 | 0.0391 | 10.0000 |
|
| LN-229 | SMER-3 | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | SN-38 | GDSC1,GDSC2,CTRP2,CTRP1 | 0.0000 | 1.3000 |
|
| LN-229 | SNS-032 | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | SNX-2112 | GDSC1,CTRP2,CTRP1 | 0.0010 | 33.0000 |
|
| LN-229 | SNX-2112:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 |
|
| LN-229 | Sorafenib | GDSC2,CTRP2,CCLE | 0.0020 | 66.0000 |
|
| LN-229 | sparfosic acid | CTRP1 | 2.0833 | 266.6700 |
|
| LN-229 | spautin-1 | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | Sphingosine Kinase 1 Inhibitor II | GDSC1,CTRP2 | 0.0010 | 33.0000 |
|
| LN-229 | SR-II-138A | CTRP2,CTRP1 | 0.0010 | 33.0000 |
|
| LN-229 | SR1001 | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | Staurosporine | GDSC2,CTRP2 | 0.0001 | 3.3000 |
|
| LN-229 | StemRegenin 1 | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | STF-31 | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | STF-62247 | GDSC1 | 0.0400 | 10.2400 |
|
| LN-229 | SU11274 | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | Sunitinib | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | T-5345967 | CTRP2,CTRP1 | 0.0160 | 533.3300 |
|
| LN-229 | T0901317 | GDSC1 | 0.0400 | 10.2400 |
|
| LN-229 | tacrolimus | CTRP2,CTRP1 | 0.0023 | 74.0000 |
|
| LN-229 | TAF1_5496 | GDSC2 | 0.0100 | 10.0000 |
|
| LN-229 | TAK-715 | GDSC1 | 0.0781 | 20.0000 |
|
| LN-229 | Talazoparib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LN-229 | tamatinib | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| LN-229 | Tamoxifen | GDSC1,GDSC2,CTRP2,CTRP1 | 0.0030 | 100.0000 |
|
| LN-229 | tandutinib | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | Tanespimycin | CTRP1,CCLE,GDSC1,GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| LN-229 | tanespimycin:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 |
|
| LN-229 | tanespimycin:gemcitabine (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| LN-229 | TANK_1366 | GDSC1 | 0.0098 | 2.5000 |
|
| LN-229 | Taselisib | GDSC2 | 0.0040 | 10.0000 |
|
| LN-229 | Telomerase Inhibitor IX | GDSC2,CTRP2,CTRP1 | 0.0010 | 37.0000 |
|
| LN-229 | Temozolomide | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | Temsirolimus | GDSC1,GDSC2,CTRP2 | 0.0008 | 66.0000 |
|
| LN-229 | Teniposide | GDSC2,CTRP2,CTRP1 | 0.0010 | 33.0000 |
|
| LN-229 | Tenovin-6 | GDSC1 | 0.0781 | 20.0000 |
|
| LN-229 | TG-100-115 | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | TGX-115 | CTRP1 | 4.1667 | 533.3300 |
|
| LN-229 | TGX221 | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | Thapsigargin | GDSC1 | 0.0020 | 0.5120 |
|
| LN-229 | THR-101 | GDSC2 | 0.0100 | 10.0000 |
|
| LN-229 | THR-102 | GDSC2 | 0.0100 | 10.0000 |
|
| LN-229 | THR-103 | GDSC2 | 0.0100 | 10.0000 |
|
| LN-229 | THZ-2-102-1 | GDSC1 | 0.0098 | 2.5000 |
|
| LN-229 | THZ-2-49 | GDSC1 | 0.0781 | 20.0000 |
|
| LN-229 | tigecycline | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | Tipifarnib | GDSC1 | 0.0625 | 16.0000 |
|
| LN-229 | tipifarnib-P1 | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| LN-229 | tipifarnib-P2 | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| LN-229 | Tivozanib | GDSC1,CTRP2,CTRP1 | 0.0005 | 33.3330 |
|
| LN-229 | TKI258 | CCLE | 0.0025 | 8.0000 |
|
| LN-229 | TL-1-85 | GDSC1 | 0.0400 | 10.2400 |
|
| LN-229 | TL-2-105 | GDSC1 | 0.0400 | 10.2400 |
|
| LN-229 | Topotecan | GDSC2,CTRP2,CCLE | 0.0020 | 66.0000 |
|
| LN-229 | Torin 2 | GDSC1 | 0.0781 | 20.0000 |
|
| LN-229 | tosedostat | CTRP2,CTRP1 | 0.0081 | 270.0000 |
|
| LN-229 | Tozasertib | CTRP1 | 0.2604 | 33.3330 |
|
| LN-229 | TPCA-1 | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | Trametinib | GDSC1,GDSC2 | 0.0010 | 1.0000 |
|
| LN-229 | Tretinoin | GDSC1,CTRP2,CTRP1 | 0.0041 | 133.3300 |
|
| LN-229 | tretinoin:carboplatin (2:1 mol-mol) | CTRP2 | 0.0030 | 100.0000 |
|
| LN-229 | tretinoin:navitoclax (4:1 mol-mol) | CTRP2 | 0.0025 | 83.0000 |
|
| LN-229 | triacsin C | CTRP1 | 0.2604 | 33.3330 |
|
| LN-229 | Trichostatin A | GDSC1 | 0.0040 | 1.0240 |
|
| LN-229 | trifluoperazine | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| LN-229 | triptolide | CTRP2,CTRP1 | 0.0000 | 0.2900 |
|
| LN-229 | TTK_3146 | GDSC1 | 0.0391 | 10.0000 |
|
| LN-229 | TTNBP | CTRP1 | 0.0260 | 3.3333 |
|
| LN-229 | Tubastatin A | GDSC1,CTRP2,CTRP1 | 0.0020 | 33.3330 |
|
| LN-229 | TW 37 | GDSC1,CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| LN-229 | TWS119 | GDSC1 | 0.0781 | 20.0000 |
|
| LN-229 | tyrphostin AG-1478 | CTRP1 | 1.4787 | 189.2800 |
|
| LN-229 | ubistatin B | CTRP1 | 4.1667 | 533.3300 |
|
| LN-229 | UK 356618 | CTRP1 | 0.2604 | 33.3330 |
|
| LN-229 | Ulixertinib | GDSC2 | 0.0020 | 10.0000 |
|
| LN-229 | ULK1_4989 | GDSC2 | 0.0300 | 30.0000 |
|
| LN-229 | UMI-77 | GDSC2 | 0.0100 | 10.0000 |
|
| LN-229 | UNC0321 | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| LN-229 | UNC0379 | GDSC2 | 0.0100 | 10.0000 |
|
| LN-229 | UNC0638 | GDSC1,GDSC2,CTRP2,CTRP1 | 0.0010 | 40.0000 |
|
| LN-229 | UNC0642 | GDSC1 | 0.0020 | 0.5000 |
|
| LN-229 | UNC1215 | GDSC1 | 0.0039 | 1.0000 |
|
| LN-229 | Uprosertib | GDSC2 | 0.0100 | 10.0000 |
|
| LN-229 | ursolic acid | CTRP1 | 1.8247 | 233.5600 |
|
| LN-229 | valdecoxib | CTRP2,CTRP1 | 0.0180 | 600.0000 |
|
| LN-229 | vandetanib | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | VE-822 | GDSC2 | 0.0050 | 5.0000 |
|
| LN-229 | VE821 | GDSC2 | 0.0100 | 10.0000 |
|
| LN-229 | Veliparib | GDSC1,GDSC2,CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| LN-229 | Venetoclax | GDSC2 | 0.0010 | 1.0000 |
|
| LN-229 | Venotoclax | GDSC1 | 0.0010 | 0.2560 |
|
| LN-229 | VER-155008 | CTRP2,CTRP1 | 0.0011 | 37.0000 |
|
| LN-229 | Vinblastine | GDSC1,GDSC2 | 0.0001 | 0.1000 |
|
| LN-229 | Vincristine | GDSC2,CTRP2 | 0.0030 | 130.0000 |
|
| LN-229 | Vinorelbine | GDSC1,GDSC2 | 0.0001 | 0.1000 |
|
| LN-229 | Vismodegib | GDSC1,GDSC2,CTRP1 | 0.0100 | 33.3330 |
|
| LN-229 | VNLG-124 | GDSC1 | 0.0200 | 5.1200 |
|
| LN-229 | vorapaxar | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | Vorinostat | GDSC1,GDSC2,CTRP2,CTRP1 | 0.0010 | 37.0000 |
|
| LN-229 | vorinostat:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | vorinostat:navitoclax (4:1 mol-mol) | CTRP2 | 0.0020 | 2.1000 |
|
| LN-229 | Voxtalisib | GDSC1 | 0.0781 | 20.0000 |
|
| LN-229 | VSP34_8731 | GDSC2 | 0.0300 | 30.0000 |
|
| LN-229 | VTP-A | GDSC2 | 0.0010 | 1.0000 |
|
| LN-229 | VTP-B | GDSC2 | 0.0010 | 1.0000 |
|
| LN-229 | VU0155056 | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | VX-11e | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LN-229 | VX-702 | GDSC1 | 0.0078 | 2.0000 |
|
| LN-229 | WAY-362450 | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | Wee1 Inhibitor | GDSC1,GDSC2 | 0.0078 | 10.0000 |
|
| LN-229 | WEHI-539 | GDSC2 | 0.0100 | 10.0000 |
|
| LN-229 | WHI-P97 | GDSC1 | 0.0400 | 10.2400 |
|
| LN-229 | WIKI4 | GDSC2 | 0.0100 | 10.0000 |
|
| LN-229 | Wnt-C59 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LN-229 | WP1130 | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | WT-161 | CTRP1 | 0.2604 | 33.3330 |
|
| LN-229 | WYE-125132 | GDSC1 | 0.0400 | 10.2400 |
|
| LN-229 | WZ3105 | GDSC1 | 0.0050 | 1.2800 |
|
| LN-229 | WZ4003 | GDSC2 | 0.0100 | 10.0000 |
|
| LN-229 | WZ8040 | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | XAV939 | GDSC1,GDSC2,CTRP1 | 0.0100 | 37.0000 |
|
| LN-229 | XL765 | CTRP2 | 0.0020 | 33.0000 |
|
| LN-229 | XMD13-2 | GDSC1 | 0.0400 | 10.2400 |
|
| LN-229 | XMD14-99 | GDSC1 | 0.0400 | 10.2400 |
|
| LN-229 | XMD15-27 | GDSC1 | 0.0400 | 10.2400 |
|
| LN-229 | Y-39983 | GDSC1 | 0.0781 | 20.0000 |
|
| LN-229 | YK-4-279 | GDSC1,GDSC2,CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| LN-229 | YL54 | CTRP2 | 0.0020 | 66.0000 |
|
| LN-229 | YM201636 | GDSC1 | 0.0200 | 5.1200 |
|
| LN-229 | ZD-6474 | CCLE | 0.0025 | 8.0000 |
|
| LN-229 | zebularine | CTRP2,CTRP1 | 0.0180 | 592.0000 |
|
| LN-229 | Zibotentan | GDSC1 | 0.0781 | 20.0000 |
|
| LN-229 | zileuton | CTRP1 | 4.1667 | 533.3300 |
|
| LN-229 | ZL049 | GDSC1 | 0.0391 | 10.0000 |
|
| LN-229 | ZL109 | GDSC1 | 0.0391 | 10.0000 |
|
| LN-229 | ZM336372 | CTRP1 | 2.6747 | 342.3700 |
|
| LN-229 | ZM447439 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LN-229 | Zoledronate | GDSC2 | 0.0020 | 2.0000 |
|
| LN-229 | ZSTK474 | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
IC50
IC50 indicates how much drug dosage is needed to inhibit the cells by 50%, in vitro, compared to the control well.
Drugs with highest and lowest IC50
Drugs with highest and lowest IC50
IC90
IC90 indicates how much drug dosage is needed to inhibit the cells by 90%, in vitro, compared to the control well.
Drugs with highest and lowest IC90
Drugs with highest and lowest IC90
AUC
AUC represents the area under a dose-response curve, where 0% indicates no activity and 100% indicates that a drug completely inhibits the cells across testing dosages.
Drugs with highest and lowest AUC
Drugs with highest and lowest AUC